EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of an evolutionarily distinct evasin with dual CC and CXC chemokine inhibitory activity

Surendra Kunwar, Shankar Raj Devkota, Caroline Ang, Pramod Aryal, Wenrui Gai, Rina Pokhrel, Sean S So, Wanting Jiao, Richard J Payne, Remy Robert, Martin J Stone, Ram Prasad Bhusal

Structure · 2026

DOI: 10.1016/j.str.2026.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2026. Verfasst von Surendra Kunwar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology and Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia. Hauptthemen laut MEDLINE: Chemokines, CXC, Chemokines, CC. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Research to Prevent Blindness, Ocean University of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemokine-driven leukocyte trafficking is central to the pathogenesis of cancer and autoimmune/inflammatory diseases. Therapeutic targeting of the chemokine system has largely failed due to promiscuous binding between chemokines and their receptors. Blood-feeding ticks evade immune responses by secreting salivary evasins that selectively bind and neutralize either CC or CXC chemokines. Here, we describe EVA-ATL1001 (EVA-ATL), an evasin with dual CC/CXC inhibitory function. Like other class A evasins, EVA-ATL engages CC chemokines through conserved hydrogen bonds between its β1 region and the chemokine CC motif. Remarkably, the same interface accommodates CXC chemokines with minor structural adjustments. This dual recognition is mediated primarily by a shallow hydrophobic pocket, along with contributions from the N-terminus and β1-β2 region, features absent in other evasins. EVA-ATL represents a natural evasin with broad-spectrum CC/CXC chemokine inhibition, offering a promising framework for next-generation immunotherapeutics for complex pathologies involving both chemokine families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokines, CXCChemokines, CCAnimalsHumansProtein BindingModels, MolecularAmino Acid SequenceBinding SitesEvolution, MolecularCrystallography, X-RayHydrogen Bonding

Stichwörter der Autor:innen

CC/CXC chemokine inhibitorautoimmune/inflammatory diseaseschemokine-inhibiting proteinstick evasins

Substanzen

Chemokines, CXCChemokines, CC

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology and Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Department of Physiology and Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Key Laboratory of Marine Drugs Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, People's Republic of China.
  • Ferrier Research Institute, Victoria University of Wellington, Wellington 6140, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland 1142, New Zealand.
  • School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, NSW 2006, Au…
  • Department of Biochemistry and Molecular Biology and Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia. Electronic address: martin.stone@monash.edu.

Förderung

  • China Scholarship Council
  • Research to Prevent Blindness
  • Ocean University of China
  • National Health and Medical Research Council

Zitieren

APA

Kunwar, S., Devkota, S. R., Ang, C., Aryal, P., Gai, W., Pokhrel, R., So, S. S., Jiao, W., Payne, R. J., Robert, R., Stone, M. J., & Bhusal, R. P. (2026). Discovery of an evolutionarily distinct evasin with dual CC and CXC chemokine inhibitory activity. Structure. https://doi.org/10.1016/j.str.2026.02.001

Vancouver

Kunwar S, Devkota SR, Ang C, Aryal P, Gai W, Pokhrel R, et al. Discovery of an evolutionarily distinct evasin with dual CC and CXC chemokine inhibitory activity. Structure. 2026. doi:10.1016/j.str.2026.02.001

BibTeX
@article{Kunwar2026,
  author = {Kunwar, Surendra and Devkota, Shankar Raj and Ang, Caroline and Aryal, Pramod and Gai, Wenrui and Pokhrel, Rina and So, Sean S and Jiao, Wanting and Payne, Richard J and Robert, Remy and Stone, Martin J and Bhusal, Ram Prasad},
  title = {Discovery of an evolutionarily distinct evasin with dual CC and CXC chemokine inhibitory activity},
  journal = {Structure},
  year = {2026},
  doi = {10.1016/j.str.2026.02.001}
}
Kostenlos starten →